Search research articles
Contact Us
Filters
Showing results (31-40 of 106) with videos related to
Page
of 11
Sort By:
American Journal of Clinical Oncology
|
January 1, 1988
Histological and functional changes of the testis tissue during GnRH agonist treatment of prostatic cancer
I Huhtaniemi, H Nikula, M Parvinen, et al.
International Journal of Andrology
|
October 1, 1991
Combination of a GnRH agonist with an antiandrogen or bromocriptine in the treatment of prostatic cancer; slight potentiation of antigonadal effects
I Huhtaniemi, M Parvinen, P Venho, et al.
Journal of Steroid Biochemistry
|
January 1, 1986
Regulation of testicular steroidogenesis by gonadotropin-releasing hormone agonists and antagonists
I Huhtaniemi, H Nikula, S Rannikko, et al.
European Urology
|
January 1, 1986
T0 carcinoma of the prostate: influence of tumor extent and histologic grade on prognosis of untreated patients
R Haapiainen, S Rannikko, J Mäkinen, et al.
The Prostate
|
January 1, 1988
Pretreatment plasma levels of testosterone and sex hormone binding globulin binding capacity in relation to clinical staging and survival in prostatic cancer patients
R Haapiainen, S Rannikko, O Alfthan, et al.
Annales Chirurgiae Et Gynaecologiae
|
January 1, 1989
Early experience with percutaneous nephrolithotomy
K Lehtoranta, O Lindell, S Rannikko, et al.
Annales Chirurgiae Et Gynaecologiae
|
May 7, 1999
Prostate cancer--the snowball is rolling
M Ruutu, J Salo, S Nordling, et al.
Annales Chirurgiae Et Gynaecologiae
|
January 1, 1991
Results of the management of ureteric stones with the ureterorenoscope
K Lehtoranta, S Rannikko, O Lindell, et al.
Journal of Andrology
|
January 1, 1991
Response of circulating gonadotropin levels to GnRH agonist treatment in prostatic cancer
I Huhtaniemi, P Venho, G Jacobi, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum
|
January 1, 1988
Pretreatment hormone levels in prostatic cancer
R Haapiainen, S Rannikko, O Alfthan, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 106) with videos related to
Sort By:
Page
of 11
American Journal of Clinical Oncology
|
January 1, 1988
Histological and functional changes of the testis tissue during GnRH agonist treatment of prostatic cancer
I Huhtaniemi, H Nikula, M Parvinen, et al.
International Journal of Andrology
|
October 1, 1991
Combination of a GnRH agonist with an antiandrogen or bromocriptine in the treatment of prostatic cancer; slight potentiation of antigonadal effects
I Huhtaniemi, M Parvinen, P Venho, et al.
Journal of Steroid Biochemistry
|
January 1, 1986
Regulation of testicular steroidogenesis by gonadotropin-releasing hormone agonists and antagonists
I Huhtaniemi, H Nikula, S Rannikko, et al.
European Urology
|
January 1, 1986
T0 carcinoma of the prostate: influence of tumor extent and histologic grade on prognosis of untreated patients
R Haapiainen, S Rannikko, J Mäkinen, et al.
The Prostate
|
January 1, 1988
Pretreatment plasma levels of testosterone and sex hormone binding globulin binding capacity in relation to clinical staging and survival in prostatic cancer patients
R Haapiainen, S Rannikko, O Alfthan, et al.
Annales Chirurgiae Et Gynaecologiae
|
January 1, 1989
Early experience with percutaneous nephrolithotomy
K Lehtoranta, O Lindell, S Rannikko, et al.
Annales Chirurgiae Et Gynaecologiae
|
May 7, 1999
Prostate cancer--the snowball is rolling
M Ruutu, J Salo, S Nordling, et al.
Annales Chirurgiae Et Gynaecologiae
|
January 1, 1991
Results of the management of ureteric stones with the ureterorenoscope
K Lehtoranta, S Rannikko, O Lindell, et al.
Journal of Andrology
|
January 1, 1991
Response of circulating gonadotropin levels to GnRH agonist treatment in prostatic cancer
I Huhtaniemi, P Venho, G Jacobi, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum
|
January 1, 1988
Pretreatment hormone levels in prostatic cancer
R Haapiainen, S Rannikko, O Alfthan, et al.
Page
of 11